NXTC
Price
$0.97
Change
+$0.02 (+2.11%)
Updated
Dec 20 closing price
67 days until earnings call
ORMP
Price
$2.38
Change
-$0.11 (-4.42%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
Ad is loading...

NXTC vs ORMP

Header iconNXTC vs ORMP Comparison
Open Charts NXTC vs ORMPBanner chart's image
NextCure
Price$0.97
Change+$0.02 (+2.11%)
Volume$54.8K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.38
Change-$0.11 (-4.42%)
Volume$2.34K
CapitalizationN/A
NXTC vs ORMP Comparison Chart
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. ORMP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (NXTC: $0.97 vs. ORMP: $2.37)
Brand notoriety: NXTC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 47% vs. ORMP: 66%
Market capitalization -- NXTC: $27.17M vs. ORMP: $95.94M
NXTC [@Biotechnology] is valued at $27.17M. ORMP’s [@Biotechnology] market capitalization is $95.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than NXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • NXTC’s TA Score: 4 bullish, 5 bearish.
  • ORMP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NXTC is a better buy in the short-term than ORMP.

Price Growth

NXTC (@Biotechnology) experienced а -10.19% price change this week, while ORMP (@Biotechnology) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

NXTC is expected to report earnings on Feb 27, 2025.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($95.9M) has a higher market cap than NXTC($27.2M). ORMP YTD gains are higher at: 2.597 vs. NXTC (-14.912). ORMP has higher annual earnings (EBITDA): 9.44M vs. NXTC (-57.53M). ORMP has more cash in the bank: 142M vs. NXTC (75.3M). ORMP has less debt than NXTC: ORMP (429K) vs NXTC (5.39M). NXTC (0) and ORMP (0) have equivalent revenues.
NXTCORMPNXTC / ORMP
Capitalization27.2M95.9M28%
EBITDA-57.53M9.44M-610%
Gain YTD-14.9122.597-574%
P/E RatioN/A21.64-
Revenue00-
Total Cash75.3M142M53%
Total Debt5.39M429K1,256%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCORMP
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRTTF0.620.04
+6.72%
Dirtt Environmental Solutions Ltd
IPXHY12.450.20
+1.63%
Inpex Corp.
LZAGF587.152.77
+0.47%
Lonza Group AG
SPKKY7.920.01
+0.13%
Spark New Zealand Limited
CYTOF0.12-0.18
-60.07%
Altamira Therapeutics Ltd

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+2.11%
CYTK - NXTC
37%
Loosely correlated
+4.56%
FATE - NXTC
35%
Loosely correlated
+1.20%
ORMP - NXTC
33%
Poorly correlated
-4.82%
GOSS - NXTC
32%
Poorly correlated
-0.11%
ALT - NXTC
29%
Poorly correlated
+0.86%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.82%
BPMC - ORMP
44%
Loosely correlated
+1.36%
BTAI - ORMP
44%
Loosely correlated
+8.12%
INO - ORMP
44%
Loosely correlated
-0.27%
MBIO - ORMP
44%
Loosely correlated
+1.64%
VERV - ORMP
44%
Loosely correlated
+11.24%
More